Protalix BioTherapeutics Reports Third Quarter 2022 Financial and Business Results

Company to host conference call and webcast today at 8:30 a.m. EST CARMIEL, Israel, Nov. 14, 2022 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.